Please login to the form below

medicines optimisation

This page shows the latest medicines optimisation news and features for those working in and with pharma, biotech and healthcare.

UK pharma to work with innovation network on NHS uptake

The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of medicines and other 'biomedical innovations' ... These areas include economic growth, digital

Latest news

Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down

Strong launches for new medicines Ocrevus, Tecentriq and Alecensa, especially in Germany, partially offset the loss in Europe. ... The FreeStyle Libre has not been formally reviewed by NICE, but by England’s new network of Regional Medicines
NHS seeks 'solution creators' from within pharma

There has also been “a degree of convergence” among the people and bodies that work on assessing new medicines, he added, whether they be involved with NICE, the Cancer Drugs Fund ... However, a warning note about partnership working was sounded by
Pharma could make more of its real world evidence

But pharmaceutical companies do – and they are perfectly placed to help the NHS improve medicines optimisation. ... In reality, many pharma companies have adapted their operations to develop processes and strategies to collect RWE for their medicines.
Industry pays £310m to underwrite medicines bills

Industry agreed to the PPRS in order to improve the use of innovative medicines in the UK. ... We are working with the Department of Health, NHS England and government to ensure action in key areas such as changes to NICE's decision making framework and
Patients should have a say in their medication, claims NICE

Paul Chrisp, programme director for the medicines and prescribing centre at NICE, said: “The NICE guideline on medicines optimisation sets out what needs to be done by all health and social ... Medicines optimisation is not a new concept. “This

More from news
Approximately 10 fully matching, plus 16 partially matching documents found.

Latest Intelligence

Case study: OptiMiSe for MS nurses

OptiMiSe is an innovative meetings based learning journey developed in line with the NICE Quality Standards for MS and the Royal Pharmaceutical Society’s (RPS) four principles of medicines optimisation: ... Furthermore, 100% of the MSSNs engaged in
Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?

In recent years, biosimilars (highly similar copies of biologic medicines) have taken large shares of many markets. ... Considerable effort was directed towards medicines optimisation and building an evidence base for the wider use of NOACs in
How AbbVie Care is putting patients at the centre

Industry must assume a responsibility to move beyond just the manufacture of medicines. ... Create a reliable supply chain ensuring that patients get the right medicine at the right time, supporting medicines optimisation.
It's time to get diabetes right

All with negative implications for patients - but to date focusing on specialist medicines. ... It is clear that the medicines optimisation agenda is of more importance now than ever.
Communicating value

The global recession has changed the way the industry needs to market its medicines. ... In England the NHS-driven Medicines Optimisation programme will this year engage local payers and providers on the ability of good medicines usage to improve patient

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

ABPI names NHS partnership manager

In his new role, he will manage the four ABPI regional partnership managers and lead ABPI activities in academic health science networks and medicines optimisation. ... ensure appropriate medicines and technologies are available to all eligible

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Spotlight on innovation at life sciences forum

The Government recently announced changes to the AAC to ensure that the most promising medicines, diagnostic tools and digital services get through the clinical development and regulatory approval process faster. ... and provide insights into how
NHS medicines optimisation milestone

Regional Medicines Optimisation Committees(RMOCs), which were launched last year, have been playing a pivotal role in working with NHS commissioners and providers on best value biologics and helping them to ... by 2020/21 if the NHS embraces the use of
Sir Bruce Keogh is appointed chair of judges for HSJ Awards

The eight new awards include acute or specialist services redesign, patient digital participation, creating a supportive staff culture and optimisation of medicines management.
Unique forum will unite NHS and industry to drive innovation

The event aims to help industry develop stronger relationships with leaders from NHS England, Regional Medicines Optimisation Committees (RMOCs), Sustainability and Transformation Partnerships (STPs) and Integrated Care Systems (ICSs), and influence
How will the NHS’s new medicines savings drive affect pharma?

The CCGs will be monitored by four Regional Medicines Optimisation Committees(RMOCs) which were launched recently to avoid duplication when evaluating medicines, particularly those which are not evaluated by NICE. . ... Thanks to powerful data analytics